StudyRareStudyRare
Log in to add personal notes on this page.

During anesthesia for routine surgery, a 25-year-old develops rapidly rising temperature, muscle rigidity, hypercarbia, and metabolic acidosis. The anesthesiologist stops the triggering agents and administers dantrolene.

AD; gain of function in the muscle calcium-release machinery: RYR1 (60% to 70%), CACNA1S (about 1%), STAC3 (under 1%); no variant is found in up to 40%.

  • RYR1 encodes ryanodine receptor 1, the calcium release channel of the sarcoplasmic reticulum in skeletal muscle
  • CACNA1S encodes the alpha-1S subunit of the L-type voltage-gated calcium channel (the dihydropyridine receptor) in the transverse tubule membrane
  • STAC3 encodes an adapter protein that binds the dihydropyridine receptor and is required for it to open ryanodine receptor 1

In excitation-contraction coupling, an action potential runs down the transverse tubule, and the dihydropyridine receptor senses the depolarization and opens ryanodine receptor 1 in the adjacent sarcoplasmic reticulum. The stored calcium that floods out drives contraction.

Pathogenic variants in all three genes make the release channel more sensitive to its activators. Volatile anesthetics and succinylcholine at therapeutic doses do not open a normal channel, but they open a sensitized one, and calcium release becomes uncontrolled. Each crisis feature follows:

  • Rigidity and heat: sustained contraction, with heat production.
  • Hypercapnia and acidosis: more oxygen use, more carbon dioxide, and lactic acid.
  • High CK and potassium: hypercontracture damages the cell membrane; CK release can injure the kidney, and potassium can cause fatal arrhythmia.
  • Dantrolene: inhibits calcium release through the ryanodine receptor, reversing the process.

Because the mechanism is gain of function, deletions are not expected, and functional data are critical to call a variant pathogenic. Penetrance of RYR1-related susceptibility is incomplete: 40.6% in one case-control study and likely under 5% from population data.

  • Triggered by volatile anesthetics (halothane, sevoflurane) and succinylcholine
  • Hyperthermia, muscle rigidity
  • Hypercarbia, metabolic acidosis
  • Rhabdomyolysis (elevated CK), hyperkalemia
  • Can be fatal without treatment

Testing: Muscle contracture test (caffeine-halothane); genetic testing

  • Acute crisis is a clinical diagnosis: hypercarbia, hyperthermia, rigidity, tachycardia, and metabolic/respiratory acidosis after a triggering agent; elevated CK and hyperkalemia support it
  • Caffeine-halothane (in vitro) contracture test on fresh muscle biopsy is the gold standard for susceptibility
  • Molecular testing of RYR1 and CACNA1S confirms susceptibility and enables targeted family testing
  • Susceptibility is often identified after an index event or a positive family history; counsel relatives and offer cascade testing
  • Dantrolene (reverses calcium release), supportive care

"CentRal coRe disease = Ryanodine Receptor RYR1": RYR1 variants cause both malignant hyperthermia susceptibility and central core disease (a congenital myopathy). The "R" pattern in "centRal coRe" points to the Ryanodine Receptor.

"EYE of the storm = RYR1": The "RY" in RYR looks like an eye, and the storm represents the metabolic crisis triggered by anesthetics.

"Overheat": Malignant hyperthermia = uncontrolled calcium release causing sustained muscle contraction and dangerous heat production.